Recent research discoveries revealed that while the CD1A+CD207+ histiocytes are the hallmark of LCH, other BRAF-mutated peripheral blood mononuclear cell populations (such as NK cells and granulocytes) may contribute to the substantial diversity of LCH clinical manifestations. The gene discussed is CD207; the disease is Langerhans cell histiocytosis.